Phenaris

Phenaris is a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

https://www.phenaris.com/

Latest Tweets

Edelweiss Connect (5 weeks ago)
Still time to submit a poster for consideration at the #OpenTox 2022 Virtual Conference The deadline for poster an… https://t.co/XWoGIEpHAn
Edelweiss Connect (2 months ago)
Interested in using a Next Generation #riskassessment Solution? @EdelweissConn plays a leading role in RISK-HUNT3R… https://t.co/XHA2Lr97Bn
Edelweiss Connect (2 months ago)
Join us on August 30 at 16 CEST for the first installment of the #SaferWorldbyDesign: Working days of a cosmetic sa… https://t.co/8yebpqb1Nh
Edelweiss Connect (3 months ago)
We are proud to announce that the catalog of #SaferWorldbyDesign products and services is now available through bot… https://t.co/c6wV90Rh0t
Edelweiss Connect (3 months ago)
SWBD provider SenzaGen obtains OECD approval for GARD®skin #saferskin #skincare #invitro #oecd #machinelearning… https://t.co/OLKn5Jl8Pi

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA